{
  "id": 19304684,
  "title": "London biotech Oyster harvests $60M for tau-targeting brain drugs",
  "url": "https://urgent.news/2026/11/10/london-biotech-oyster-harvests-60m-for-tau-targeting-brain-drugs",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-10T07:00:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/oyster-venture-financing-tau-targeted-protein-degraders/874160/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Oyster says a tweak it's made to traditional protein degrading technology can help break down tau, which has long been a focus of Alzheimer’s drug research.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}